It’s hard to go wrong with either company, but one is more appealing. Viking Therapeutics (VKTX 5.43%) and Summit Therapeutics (SMMT 7.20%) are both up-and-coming biotechs…
Author: FinMar News
Trump appeared to be heckled at his California rally. Hear how he responded Politico White House reporter Daniel Lippman joins CNN’s Victor Blackwell to discuss why…
Guillaume Le Grand is trying to bring cargo shipping back to its roots.Standing on the deck of an 82-metre sailboat docked in Quebec City’s port, Le…
In This StoryAfter a hectic week filled with major earnings reports, an AI summit, robotaxis, and key inflation data, this coming week will be shorter but…
Key InsightsHeadlam Group’s estimated fair value is UK£1.78 based on 2 Stage Free Cash Flow to EquityHeadlam Group’s UK£1.32 share price signals that it might be…
Simon Redfern’s Open Bank Project aims to revolutionize banking by promoting transparency and open-source innovation through standardized APIs. Redfern’s recent work focuses on bridging open banking…
(Bloomberg) — China’s highly anticipated Finance Ministry briefing on Saturday lacked the firepower that equity investors had hoped for, indicating that the volatility that’s gripped the…
Floridians recovering from Hurricane Milton, many of whom were journeying home after fleeing hundreds of miles to escape the storm, spent much of Saturday searching for…
Nvidia’s stock has enjoyed incredible gains over the last five years. It’s only natural for competitors to pop up. The artificial intelligence chipmaker Nvidia (NVDA -0.01%)…
Many prospective homebuyers have been discouraged the past year because of the challenging real estate market which has been plagued by high prices, high mortgage rates,…